http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101452520-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2007-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101452520-B1
titleOfInvention Pyrrolo [3,2-C] pyridin-4-one 2-indolinone protein kinase inhibitor
abstract The present invention relates to pyrrolo [3,2-c] pyridin-4-one 2-indolinone compounds of formula I and their pharmaceutically acceptable salts:n n n Formula In n n n n n n n In this formula,n n n R1, R2, R3, R4, R5, R6, R7, R8, X, Y and Have the meanings as defined in the specification.n n n Also described are pharmaceutical compositions containing the compounds described above, their preparation and their pharmaceutical uses, in particular their use as protein kinase inhibitors.
priorityDate 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03027114-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24743028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467834790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24742179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24743109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16662431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58544073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423944027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24743195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423159857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58544068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408849874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58544052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423160173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58544070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414165990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408839691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24743283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423160246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408738017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423160297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24743193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423160167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58544031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406937843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24742097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58544065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID143515193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408353452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466921788
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24743026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423160208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465517690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408905151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410177348

Total number of triples: 69.